Medicare Program; Request for Nominations for Members for the Medicare Evidence Development & Coverage Advisory Committee, 51915-51916 [2016-18545]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 151 / Friday, August 5, 2016 / Notices
Dated: August 2, 2016.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2016–18664 Filed 8–4–16; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3335–N]
Medicare Program; Request for
Nominations for Members for the
Medicare Evidence Development &
Coverage Advisory Committee
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
This notice announces the
request for nominations for membership
on the Medicare Evidence Development
& Coverage Advisory Committee
(MEDCAC). Among other duties, the
MEDCAC provides advice and guidance
to the Secretary of the Department of
Health and Human Services (the
Secretary) and the Administrator of the
Centers for Medicare & Medicaid
Services (CMS) concerning the
adequacy of scientific evidence
available to CMS in making coverage
determinations under the Medicare
program.
The MEDCAC reviews and evaluates
medical literature and technology
assessments, and hears public testimony
on the evidence available to address the
impact of medical items and services on
health outcomes of Medicare
beneficiaries.
SUMMARY:
Nominations must be received
by Tuesday, September 6, 2016.
ADDRESSES: You may mail nominations
for membership to the following
address: Centers for Medicare &
Medicaid Services, Center for Clinical
Standards and Quality, Attention: Maria
Ellis, 7500 Security Boulevard, Mail
Stop: S3–02–01, Baltimore, MD 21244
or send via email to
MEDCACnomination@cms.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Maria Ellis, Executive Secretary for the
MEDCAC, Centers for Medicare &
Medicaid Services, Center for Clinical
Standards and Quality, Coverage and
Analysis Group, S3–02–01, 7500
Security Boulevard, Baltimore, MD
21244 or contact Ms. Ellis by phone
(410–786–0309) or via email at
Maria.Ellis@cms.hhs.gov.
mstockstill on DSK3G9T082PROD with NOTICES
DATES:
VerDate Sep<11>2014
17:42 Aug 04, 2016
Jkt 238001
I. Background
The Secretary signed the initial
charter for the Medicare Coverage
Advisory Committee (MCAC) on
November 24, 1998. A notice in the
Federal Register (63 FR 68780)
announcing establishment of the MCAC
was published on December 14, 1998.
The MCAC name was updated to more
accurately reflect the purpose of the
committee and on January 26, 2007, the
Secretary published a notice in the
Federal Register (72 FR 3853),
announcing that the Committee’s name
changed to the Medicare Evidence
Development & Coverage Advisory
Committee (MEDCAC). The current
Secretary’s Charter for the MEDCAC is
available on the CMS Web site at: https://
www.cms.hhs.gov/FACA/Downloads/
medcaccharter.pdf, or you may obtain a
copy of the charter by submitting a
request to the contact listed in the FOR
FURTHER INFORMATION section of this
notice.
The MEDCAC is governed by
provisions of the Federal Advisory
Committee Act, Pub. L. 92–463, as
amended (5 U.S.C. App. 2), which sets
forth standards for the formulation and
use of advisory committees, and is
authorized by section 222 of the Public
Health Service Act as amended (42
U.S.C. 217A).
We are requesting nominations for
candidates to serve on the MEDCAC.
Nominees are selected based upon their
individual qualifications and not solely
as representatives of professional
associations or societies. We wish to
ensure adequate representation of the
interests of both women and men,
members of all ethnic groups, and
physically challenged individuals.
Therefore, we encourage nominations of
qualified candidates who can represent
these interests.
The MEDCAC consists of a pool of
100 appointed members including: 94
at-large standing members (6 of whom
are patient advocates), and 6
representatives of industry interests.
Members generally are recognized
authorities in clinical medicine
including subspecialties, administrative
medicine, public health, biological and
physical sciences, epidemiology and
biostatistics, clinical trial design, health
care data management and analysis,
patient advocacy, health care
economics, medical ethics or other
relevant professions.
The MEDCAC works from an agenda
provided by the Designated Federal
Official. The MEDCAC reviews and
evaluates medical literature and
technology assessments, and hears
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
51915
public testimony on the evidence
available to address the impact of
medical items and services on health
outcomes of Medicare beneficiaries. The
MEDCAC may also advise the Centers
for Medicare & Medicaid Services (CMS)
as part of Medicare’s ‘‘coverage with
evidence development’’ initiative.
II. Provisions of the Notice
As of January 2017, there will be 31
membership terms expiring. Of the 31
memberships expiring, 3 are industry
representatives, 1 is a patient advocate,
and the remaining 27 membership
openings are for the at-large standing
MEDCAC membership.
All nominations must be
accompanied by curricula vitae.
Nomination packages should be sent to
Maria Ellis at the address listed in the
ADDRESSES section of this notice.
Nominees are selected based upon their
individual qualifications. Nominees for
membership must have expertise and
experience in one or more of the
following fields:
• Clinical medicine including
subspecialties
• Administrative medicine
• Public health
• Biological and physical sciences
• Epidemiology and biostatistics
• Clinical trial design
• Health care data management and
analysis
• Patient advocacy
• Health care economics
• Medical ethics
• Other relevant professions
We are looking particularly for
experts in a number of fields. These
include cancer screening, genetic
testing, clinical epidemiology,
psychopharmacology, screening and
diagnostic testing analysis, and vascular
surgery. We also need experts in
biostatistics in clinical settings,
dementia treatment, minority health,
observational research design, stroke
epidemiology, and women’s health.
The nomination letter must include a
statement that the nominee is willing to
serve as a member of the MEDCAC and
appears to have no conflict of interest
that would preclude membership. We
are requesting that all curricula vitae
include the following:
• Date of birth
• Place of birth
• Social security number
• Title and current position
• Professional affiliation
• Home and business address
• Telephone and fax numbers
• Email address
• List of areas of expertise
In the nomination letter, we are
requesting that nominees specify
E:\FR\FM\05AUN1.SGM
05AUN1
51916
Federal Register / Vol. 81, No. 151 / Friday, August 5, 2016 / Notices
whether they are applying for a patient
advocate position, for an at-large
standing position, or as an industry
representative. Potential candidates will
be asked to provide detailed information
concerning such matters as financial
holdings, consultancies, and research
grants or contracts in order to permit
evaluation of possible sources of
financial conflict of interest. Department
policy prohibits multiple committee
memberships. A federal advisory
committee member may not serve on
more than one committee within an
agency at the same time.
Members are invited to serve for
overlapping 2-year terms. A member
may continue to serve after the
expiration of the member’s term until a
successor is named. Any interested
person may nominate one or more
qualified persons. Self-nominations are
also accepted. Individuals interested in
the representative positions must
include a letter of support from the
organization or interest group they
would represent.
Dated: July 26, 2016.
Kate Goodrich,
Director, Center for Clinical Standards and
Quality, Centers for Medicare & Medicaid
Services.
[FR Doc. 2016–18545 Filed 8–4–16; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10340 and
CMS–10630]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:42 Aug 04, 2016
Jkt 238001
any of the following subjects: The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
the accuracy of the estimated burden;
ways to enhance the quality, utility, and
clarity of the information to be
collected; and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
October 4, 2016.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/Paperwork
ReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10340 Collection of Encounter
Data From: Medicare Advantage
Organizations, Section 1876 Cost
HMOS/CMPS, Section 1833 Health
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Care Prepayment Plans (HCPPS), and
PACE Organizations
CMS–10630 The PACE Organization
(PO) Monitoring and Audit Process in
42 CFR part 460
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Collection of
Encounter Data From: Medicare
Advantage Organizations, Section 1876
Cost HMOS/CMPS, Section 1833 Health
Care Prepayment Plans (HCPPS), and
PACE Organizations; Use: We collect
encounter data or data on each item or
service delivered to enrollees of
Medicare Advantage (MA) plans offered
by MA organizations. The MA
organizations currently obtain this data
from providers. We collect this
information using standard transaction
forms and code sets. We will use the
data for determining risk adjustment
factors for payment, updating the risk
adjustment model, calculating Medicare
DSH percentages, Medicare coverage
purposes, and quality review and
improvement activities. The data is also
used to verify the accuracy and validity
of the costs claimed on cost reports. For
PACE organizations, encounter data
would serve the same purpose it does
related to the MA program and would
be submitted in a similar manner. Form
Number: CMS–10340 (OMB control
number: 0938–1152); Frequency:
Weekly, bi-weekly, and monthly;
Affected Public: Private sector (Business
or other for-profits); Number of
Respondents: 691; Total Annual
Responses: 18,854,605; Total Annual
Hours: 54,054. (For policy questions
regarding this collection contact
Michael Massimini at 410–786–1566.)
E:\FR\FM\05AUN1.SGM
05AUN1
]]>Agencies
[Federal Register Volume 81, Number 151 (Friday, August 5, 2016)]
[Notices]
[Pages 51915-51916]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-18545]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3335-N]
Medicare Program; Request for Nominations for Members for the
Medicare Evidence Development & Coverage Advisory Committee
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the request for nominations for
membership on the Medicare Evidence Development & Coverage Advisory
Committee (MEDCAC). Among other duties, the MEDCAC provides advice and
guidance to the Secretary of the Department of Health and Human
Services (the Secretary) and the Administrator of the Centers for
Medicare & Medicaid Services (CMS) concerning the adequacy of
scientific evidence available to CMS in making coverage determinations
under the Medicare program.
The MEDCAC reviews and evaluates medical literature and technology
assessments, and hears public testimony on the evidence available to
address the impact of medical items and services on health outcomes of
Medicare beneficiaries.
DATES: Nominations must be received by Tuesday, September 6, 2016.
ADDRESSES: You may mail nominations for membership to the following
address: Centers for Medicare & Medicaid Services, Center for Clinical
Standards and Quality, Attention: Maria Ellis, 7500 Security Boulevard,
Mail Stop: S3-02-01, Baltimore, MD 21244 or send via email to
MEDCACnomination@cms.hhs.gov.
FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for
the MEDCAC, Centers for Medicare & Medicaid Services, Center for
Clinical Standards and Quality, Coverage and Analysis Group, S3-02-01,
7500 Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by
phone (410-786-0309) or via email at Maria.Ellis@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The Secretary signed the initial charter for the Medicare Coverage
Advisory Committee (MCAC) on November 24, 1998. A notice in the Federal
Register (63 FR 68780) announcing establishment of the MCAC was
published on December 14, 1998. The MCAC name was updated to more
accurately reflect the purpose of the committee and on January 26,
2007, the Secretary published a notice in the Federal Register (72 FR
3853), announcing that the Committee's name changed to the Medicare
Evidence Development & Coverage Advisory Committee (MEDCAC). The
current Secretary's Charter for the MEDCAC is available on the CMS Web
site at: https://www.cms.hhs.gov/FACA/Downloads/medcaccharter.pdf, or
you may obtain a copy of the charter by submitting a request to the
contact listed in the FOR FURTHER INFORMATION section of this notice.
The MEDCAC is governed by provisions of the Federal Advisory
Committee Act, Pub. L. 92-463, as amended (5 U.S.C. App. 2), which sets
forth standards for the formulation and use of advisory committees, and
is authorized by section 222 of the Public Health Service Act as
amended (42 U.S.C. 217A).
We are requesting nominations for candidates to serve on the
MEDCAC. Nominees are selected based upon their individual
qualifications and not solely as representatives of professional
associations or societies. We wish to ensure adequate representation of
the interests of both women and men, members of all ethnic groups, and
physically challenged individuals. Therefore, we encourage nominations
of qualified candidates who can represent these interests.
The MEDCAC consists of a pool of 100 appointed members including:
94 at-large standing members (6 of whom are patient advocates), and 6
representatives of industry interests. Members generally are recognized
authorities in clinical medicine including subspecialties,
administrative medicine, public health, biological and physical
sciences, epidemiology and biostatistics, clinical trial design, health
care data management and analysis, patient advocacy, health care
economics, medical ethics or other relevant professions.
The MEDCAC works from an agenda provided by the Designated Federal
Official. The MEDCAC reviews and evaluates medical literature and
technology assessments, and hears public testimony on the evidence
available to address the impact of medical items and services on health
outcomes of Medicare beneficiaries. The MEDCAC may also advise the
Centers for Medicare & Medicaid Services (CMS) as part of Medicare's
``coverage with evidence development'' initiative.
II. Provisions of the Notice
As of January 2017, there will be 31 membership terms expiring. Of
the 31 memberships expiring, 3 are industry representatives, 1 is a
patient advocate, and the remaining 27 membership openings are for the
at-large standing MEDCAC membership.
All nominations must be accompanied by curricula vitae. Nomination
packages should be sent to Maria Ellis at the address listed in the
ADDRESSES section of this notice. Nominees are selected based upon
their individual qualifications. Nominees for membership must have
expertise and experience in one or more of the following fields:
Clinical medicine including subspecialties
Administrative medicine
Public health
Biological and physical sciences
Epidemiology and biostatistics
Clinical trial design
Health care data management and analysis
Patient advocacy
Health care economics
Medical ethics
Other relevant professions
We are looking particularly for experts in a number of fields.
These include cancer screening, genetic testing, clinical epidemiology,
psychopharmacology, screening and diagnostic testing analysis, and
vascular surgery. We also need experts in biostatistics in clinical
settings, dementia treatment, minority health, observational research
design, stroke epidemiology, and women's health.
The nomination letter must include a statement that the nominee is
willing to serve as a member of the MEDCAC and appears to have no
conflict of interest that would preclude membership. We are requesting
that all curricula vitae include the following:
Date of birth
Place of birth
Social security number
Title and current position
Professional affiliation
Home and business address
Telephone and fax numbers
Email address
List of areas of expertise
In the nomination letter, we are requesting that nominees specify
[[Page 51916]]
whether they are applying for a patient advocate position, for an at-
large standing position, or as an industry representative. Potential
candidates will be asked to provide detailed information concerning
such matters as financial holdings, consultancies, and research grants
or contracts in order to permit evaluation of possible sources of
financial conflict of interest. Department policy prohibits multiple
committee memberships. A federal advisory committee member may not
serve on more than one committee within an agency at the same time.
Members are invited to serve for overlapping 2-year terms. A member
may continue to serve after the expiration of the member's term until a
successor is named. Any interested person may nominate one or more
qualified persons. Self-nominations are also accepted. Individuals
interested in the representative positions must include a letter of
support from the organization or interest group they would represent.
Dated: July 26, 2016.
Kate Goodrich,
Director, Center for Clinical Standards and Quality, Centers for
Medicare & Medicaid Services.
[FR Doc. 2016-18545 Filed 8-4-16; 8:45 am]
BILLING CODE 4120-01-P
